# Efficacy And Safety Of Sunitinib In Women With Advanced Breast Cancer

> **NCT00471276** · PHASE2 · COMPLETED · sponsor: **Pfizer** · enrollment: 83 (actual)

## Conditions studied

- Breast Neoplasms

## Interventions

- **DRUG:** sunitinib

## Key facts

- **NCT ID:** NCT00471276
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-08
- **Primary completion:** 2010-06
- **Final completion:** 2010-06
- **Target enrollment:** 83 (ACTUAL)
- **Last updated:** 2011-07-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00471276

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00471276, "Efficacy And Safety Of Sunitinib In Women With Advanced Breast Cancer". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00471276. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*